Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 243 of 5804
-
New drug cocktail aims to shrink Hard-to-Treat colorectal tumors
Disease control ENROLLING_BY_INVITATIONA New Treatment Opportunity for Patients with Advanced Colorectal Cancer Refractory to Standard Chemotherapy: Clinical Trial of Capecitabine plus Lenvatinib Combination Therapy
Phase: PHASE1, PHASE2 • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Hormone showdown: which progestin best tames uterine cancer before surgery?
Disease control Recruiting nowThis phase II trial tests compares the effect of progestins, megestrol acetate to micronized progesterone, in treating patients with endometrial cancer and precancers of the uterus (atypical endometrial hyperplasia) before surgery. Progestins, similar to the natural hormone proge…
Phase: PHASE2 • Sponsor: New Mexico Cancer Research Alliance • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New minimally invasive technique may spare spinal fracture patients from major surgery
Disease control Not yet recruitingThis study evaluates minimally invasive vertebral augmentation combined with percutaneous fixation for the treatment of severe thoracolumbar burst fractures. Traditionally, fractures with a Load Sharing Classification (LSC) score ≥7 require corpectomy, which is associated with si…
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug aims to wake up immune system against Hard-to-Treat leukemia
Disease control Recruiting nowThe purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid leukemia (AML).
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
MS breakthrough? trial tests if older patients can ditch heavy drugs
Disease control Recruiting nowMultiple sclerosis (MS), the main central nervous system autoimmune disorder, is the first cause of non-traumatic disability in young adults and has thus significant individual consequences with elevated public health cost. It commonly starts during the third and fourth decades. …
Phase: PHASE3 • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New psoriasis drug could be cheaper alternative to tremfya
Disease control Recruiting nowIt is a multicenter randomized, double-blinded, parallel, positive-controlled, Phase 3 comparative study to evaluate the efficacy and safety of QL2106 injection to Tremfya® in Patients with Moderate to Severe Plaque Psoriasis. A total of 318 subjects are planned to be included an…
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for Hard-to-Treat lung cancer: drug combo may make surgery possible
Disease control Not yet recruitingThis is a multicenter, phase 2 non-randomized study to investigate the clinical feasibility and therapeutic efficacy of employing a MDT-based strategy in unresectable stage III ALK positive NSCLC following neoadjuvant alectinib in combination with platinum-based chemotherapy. Par…
Phase: PHASE2 • Sponsor: Wen-zhao ZHONG • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Heart stent showdown: does adding a procedure to pills prevent more heart attacks?
Disease control Not yet recruitingComparison of the incidence of major cardiovascular events between the combination of percutaneous intervention and optimal drug therapy and the optimal drug therapy alone in patients with chronic coronary syndrome. * Main RCT (Randomized Clinical Trial): Patients with chronic c…
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a common diabetes drug be the key to better stroke recovery?
Disease control Not yet recruitingIntracerebral hemorrhage (ICH) is a devastating form of acute stroke with poor clinical outcomes. Although ICH accounted only for 28.8% of incident strokes, it was responsible for nearly half of the long-term burden of stroke measured in disability-adjusted life years . In contra…
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo ablation aims to tame stubborn AFib
Disease control Not yet recruitingThe goal of this clinical trial is to test if a more complete ablation procedure works better than the standard procedure for people with long-lasting atrial fibrillation (AF). AF is a heart rhythm problem that can cause a fast or uneven heartbeat. This study will include 430 pe…
Phase: NA • Sponsor: Yunlong Wang • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Radiation plus immunotherapy shows promise in bile duct cancer trial
Disease control Not yet recruitingAccording to current clinical guidelines, first-line treatment for advanced biliary tract cancer (BTC) is the gemcitabine plus cisplatin (GC) regimen combined with immunotherapy, which has been shown to improve patient outcomes. Additionally, the combination of radiotherapy and i…
Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug aims to boost red blood cells after transplant
Disease control Not yet recruitingAllogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective therapy for hematological malignancies. Nonetheless, poor graft function remains a life-threatening complication after allo-HSCT. Poor erythroid engraftment is associated with increased bleeding events…
Phase: PHASE2, PHASE3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
AI blood test could spot deadly clotting complication in sepsis patients
Diagnosis Not yet recruitingDisseminated Intravascular Coagulation is a severe complication of septic shock, associated with high mortality, whose diagnosis relies on complex scores that are rarely used in practice. Preliminary studies have shown that increased neutrophil fluorescence is associated with Dis…
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
Could a shot replace daily HIV pills? new trial tests Two-Injection combo
Disease control Recruiting nowThe study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS-3242 plus Lenacapavir (LEN) versus continuing Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF)), in virological…
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Simpler stem cell collection could ease donor burden in Life-Threatening anemia
Disease control Not yet recruitingSevere aplastic anemia is a life-threatening bone marrow failure disorder. Haploidentical hematopoietic stem cell transplantation has become an important curative treatment option for patients who do not have an HLA-matched sibling donor. Traditionally, haploidentical transplant…
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New Three-Drug cocktail aims to wipe out stomach cancer before surgery
Disease control Not yet recruitingThe purpose of this clinical trial is to evaluate whether perioperative fruquintinib combined with sintilimab and SOX is effective in treating locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. The study will also assess the safety profile of this treatme…
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
40,000 people test app to outsmart diabetes
Prevention Recruiting nowThe overall aim of the study is to investigate the incidence of type 2 diabetes in individuals who have access to a digital intervention tool as compared with randomized controls during three years. The tool is based on self-affirmation theory and has large emphasis on self-refle…
Phase: NA • Sponsor: Region Skane • Aim: Prevention
Last updated Jun 27, 2026 14:03 UTC
-
Blood thinner duration trial aims to save limbs in severe artery disease
Disease control Recruiting nowChronic limb threatening ischemia (CLTI) is defined as ischemic foot pain at rest or non-healing foot wounds that is attributable to severe peripheral arterial disease (PAD).Revascularization is the cornerstone of therapy to relieve ischemic pain, prevent limb loss and preserve p…
Phase: PHASE3 • Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New immunotherapy combo aims to stop liver cancer return after surgery
Disease control OngoingTumor recurrence is the leading cause of death and a major bottleneck for long-term survival in patients with hepatocellular carcinoma (HCC). Therefore, there is an urgent clinical need for effective postoperative adjuvant therapies to reduce postoperative recurrence and improve …
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New heart zapping device could free patients from irregular heartbeat
Disease control Recruiting nowThe goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely and effectively treat symptomatic, drug-refractory Paroxysmal atrial fibrillation (PAF) and Persistent atrial fibrillation (PersAF). The main question it aims to…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC